Teriparatide acetate
Teriparatide acetate (Forteo) is a recombinant parathyroid hormone (PTH) agonist with an IC50 of 2 nM in HEK293 cells. Its intermittent administration promotes osteoblast-mediated bone formation over resorption, making it a key anabolic therapy for osteoporosis and a valuable tool for bone metabolism research in vitro and in vivo.
Product Specifications
Product Name Alternative
Cortical area, bone mineral content, parathyroid hormone, Parathar Acetate, Parathar acetate, osteoporosis, inhibit, Forteo, Inhibitor, hPTH (1-34) (acetate hydrate), hPTH 1-34, hPTH 1-34 (acetate salt), Teriparatide acetate, Teriparatide Acetate, PHT
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
99.67% (May vary between batches)
Solubility
DMSO:25 mg/mL (5.98 mM) ; H2O:20 mg/mL (4.79 mM)
Molecular Weight
4177.83
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
